Authors/Disclosures
|
Deniz Erten-Lyons, MD, FAAN
(FDA)
|
Dr. Erten-Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharamceuticals. |
|
Patricia L. Kramer, PhD
(Oregon Health Sciences University)
|
No disclosure on file |
|
Gogi Kumar, MD
(Dayton Children's Hospital)
|
Dr. Kumar has nothing to disclose. |
|
Shannon McWeeney
|
No disclosure on file |
|
Beth Wilmot, MS
(Oregon Health & Science University)
|
No disclosure on file |
|
|
No disclosure on file |
|
Jeffrey A. Kaye, MD, FAAN
(Oregon Hlth Sci Univ.)
|
Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care. |